Literature DB >> 15544453

Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding.

Nicolas Sluis-Cremer1, N Alpay Temiz, Ivet Bahar.   

Abstract

Nonnucleoside reverse transcriptase inhibitors (NNRTI) are a group of small hydrophobic compounds with diverse structures that specifically inhibit HIV-1 reverse transcriptase (RT). NNRTIs interact with HIV-1 RT by binding to a single site on the p66 subunit of the p66/p51 heterodimeric enzyme, termed the NNRTI-binding pocket (NNRTI-BP). This binding interaction results in both short-range and long-range distortions of RT structure. In this article, we review the structural, computational and experimental evidence of the NNRTI-induced conformational changes in HIV-1 RT and relate them to the mechanism by which these compounds inhibit HIV-1 reverse transcription.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15544453      PMCID: PMC1298242          DOI: 10.2174/1570162043351093

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  73 in total

Review 1.  Mechanistic aspects of HIV-1 reverse transcription initiation.

Authors:  David Harrich; Bill Hooker
Journal:  Rev Med Virol       Date:  2002 Jan-Feb       Impact factor: 6.989

Review 2.  Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives.

Authors:  Giuseppe Campiani; Anna Ramunno; Giovanni Maga; Vito Nacci; Caterina Fattorusso; Bruno Catalanotti; Elena Morelli; Ettore Novellino
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

Review 3.  Modulation of the oligomeric structures of HIV-1 retroviral enzymes by synthetic peptides and small molecules.

Authors:  Nicolas Sluis-Cremer; Gilda Tachedjian
Journal:  Eur J Biochem       Date:  2002-11

4.  Steered molecular dynamics simulation on the binding of NNRTI to HIV-1 RT.

Authors:  Lingling Shen; Jianhua Shen; Xiaomin Luo; Feng Cheng; Yechun Xu; Kaixian Chen; Edward Arnold; Jianping Ding; Hualiang Jiang
Journal:  Biophys J       Date:  2003-06       Impact factor: 4.033

5.  Inhibitor binding alters the directions of domain motions in HIV-1 reverse transcriptase.

Authors:  N Alpay Temiz; Ivet Bahar
Journal:  Proteins       Date:  2002-10-01

Review 6.  The effect of NNRTIs on HIV reverse transcriptase dimerization.

Authors:  Gilda Tachedjian; Stephen P Goff
Journal:  Curr Opin Investig Drugs       Date:  2003-08

7.  Mutational analysis of Tyr-501 of HIV-1 reverse transcriptase. Effects on ribonuclease H activity and inhibition of this activity by N-acylhydrazones.

Authors:  Dominique Arion; Nicolas Sluis-Cremer; Kyung-Lyum Min; Michael E Abram; Ronald S Fletcher; Michael A Parniak
Journal:  J Biol Chem       Date:  2001-10-29       Impact factor: 5.157

8.  Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA.

Authors:  Stefan G Sarafianos; Arthur D Clark; Kalyan Das; Steve Tuske; Jens J Birktoft; Palanichamy Ilankumaran; Andagar R Ramesha; Jane M Sayer; Donald M Jerina; Paul L Boyer; Stephen H Hughes; Eddy Arnold
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

9.  Structural basis for the inhibitory efficacy of efavirenz (DMP-266), MSC194 and PNU142721 towards the HIV-1 RT K103N mutant.

Authors:  Jimmy Lindberg; Snaevar Sigurdsson; Seved Löwgren; Hans O Andersson; Christer Sahlberg; Rolf Noréen; Kerstin Fridborg; Hong Zhang; Torsten Unge
Journal:  Eur J Biochem       Date:  2002-03

10.  Destabilization of the HIV-1 reverse transcriptase dimer upon interaction with N-acyl hydrazone inhibitors.

Authors:  Nicolas Sluis-Cremer; Dominique Arion; Michael A Parniak
Journal:  Mol Pharmacol       Date:  2002-08       Impact factor: 4.436

View more
  36 in total

1.  Design, synthesis, and biological evaluation of 1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils as potent HIV-1 non-nucleoside reverse transcriptase inhibitors with an improved drug resistance profile.

Authors:  Xiaowei Wang; Jianfang Zhang; Yang Huang; Ruiping Wang; Liang Zhang; Kang Qiao; Li Li; Chang Liu; Yabo Ouyang; Weisi Xu; Zhili Zhang; Liangren Zhang; Yiming Shao; Shibo Jiang; Liying Ma; Junyi Liu
Journal:  J Med Chem       Date:  2012-02-17       Impact factor: 7.446

2.  Probing nonnucleoside inhibitor-induced active-site distortion in HIV-1 reverse transcriptase by transient kinetic analyses.

Authors:  Qing Xia; Jessica Radzio; Karen S Anderson; Nicolas Sluis-Cremer
Journal:  Protein Sci       Date:  2007-08       Impact factor: 6.725

3.  Protein-mediated antagonism between HIV reverse transcriptase ligands nevirapine and MgATP.

Authors:  Xunhai Zheng; Geoffrey A Mueller; Eugene F DeRose; Robert E London
Journal:  Biophys J       Date:  2013-06-18       Impact factor: 4.033

4.  A novel mutation, D404N, in the connection subdomain of reverse transcriptase of HIV-1 CRF08_BC subtype confers cross-resistance to NNRTIs.

Authors:  Xiao-Min Zhang; Hao Wu; Qiwei Zhang; Terrence Chi-Kong Lau; Hin Chu; Zhi-Wei Chen; Dong-Yan Jin; Bo-Jian Zheng
Journal:  J Antimicrob Chemother       Date:  2015-01-29       Impact factor: 5.790

Review 5.  HIV-1 antiretroviral drug therapy.

Authors:  Eric J Arts; Daria J Hazuda
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

6.  The Role of Nucleotide Excision by Reverse Transcriptase in HIV Drug Resistance.

Authors:  Antonio J Acosta-Hoyos; Walter A Scott
Journal:  Viruses       Date:  2010-01-28       Impact factor: 5.048

7.  Rapid and persistent selection of the K103N mutation as a majority quasispecies in a HIV1-patient exposed to efavirenz for three weeks: a case report and review of the literature.

Authors:  Ennio Polilli; Giustino Parruti; Luana Cosentino; Federica Sozio; Annalisa Saracino; Augusta Consorte; Gioacchino Angarano; Francesco Di Masi; Elena Mazzotta; Paolo Fazii
Journal:  J Med Case Rep       Date:  2009-09-18

Review 8.  Murine leukemia virus reverse transcriptase: structural comparison with HIV-1 reverse transcriptase.

Authors:  Marie L Coté; Monica J Roth
Journal:  Virus Res       Date:  2008-02-21       Impact factor: 3.303

9.  HIV reverse transcriptase: structural interpretation of drug resistant genetic variants from India.

Authors:  Abraham Joseph Kandathil; Agnel Praveen Joseph; Rajesh Kannangai; Narayanaswamy Srinivasan; Oriapadickal Cherian Abraham; Susanne Alexander Pulimood; Gopalan Sridharan
Journal:  Bioinformation       Date:  2009-08-20

10.  Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase.

Authors:  Elsa D Garcin; Andrew S Arvai; Robin J Rosenfeld; Matt D Kroeger; Brian R Crane; Gunilla Andersson; Glen Andrews; Peter J Hamley; Philip R Mallinder; David J Nicholls; Stephen A St-Gallay; Alan C Tinker; Nigel P Gensmantel; Antonio Mete; David R Cheshire; Stephen Connolly; Dennis J Stuehr; Anders Aberg; Alan V Wallace; John A Tainer; Elizabeth D Getzoff
Journal:  Nat Chem Biol       Date:  2008-10-12       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.